24 Nov 2025 | 3 Mins Read
Natco Pharma shares under USFDA scrutiny
Flipitmoney
Natco Pharma received 7 observations from the USFDA, concluding an inspection at its Chennai API unit from November 17-21. The company believes the observations are procedural and confident in addressing them. The share price remains in focus, having closed at Rs 864.40, down 0.56% in the previous session.